Key result
In silico, ex vivo, and in vivo modeling technologies are rapidly advancing the understanding of heart valve biomechanics, with ex vivo simulation providing a highly promising platform for clinical translation.
Why the study?
Most valvular pathologies are rooted in biomechanical changes, but technologies for studying these pathologies and identifying treatments have largely been limited.
Design
Review
Authors
Loading...
May accelerate preclinical valve device testing; leaves open prospective validation before clinical adoption.
Ex vivo heart simulation provides a highly controlled, translatable platform that bridges the gap between computational and animal models for studying valvular biomechanics and surgical therapies.
Park et al. (2021) conducted a review in Valvular heart disease. Heart valve biomechanics modeling (in silico, ex vivo, in vivo) was evaluated. In silico, ex vivo, and in vivo modeling technologies are rapidly advancing the understanding of heart valve biomechanics, with ex vivo simulation providing a highly promising platform for clinical translation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: